.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Accenture
Cipla
Teva
McKesson
UBS
Cerilliant
US Army
Merck
Citi

Generated: June 24, 2017

DrugPatentWatch Database Preview

Isosulfan blue - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for isosulfan blue and what is the scope of isosulfan blue patent protection?

Isosulfan blue
is the generic ingredient in two branded drugs marketed by Covidien, Aurobindo Pharma Ltd, and Mylan Institutional, and is included in three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for isosulfan blue. Three suppliers are listed for this compound.

Summary for Generic Name: isosulfan blue

Tradenames:2
Patents:1
Applicants:3
NDAs:3
Drug Master File Entries: see list5
Suppliers / Packagers: see list3
Bulk Api Vendors: see list8
Clinical Trials: see list209
Patent Applications: see list5
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:isosulfan blue at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional
ISOSULFAN BLUE
isosulfan blue
INJECTABLE;INJECTION090874-001Jul 20, 2010APRXNoYes► Subscribe► Subscribe
Aurobindo Pharma Ltd
ISOSULFAN BLUE
isosulfan blue
INJECTABLE;INJECTION206831-001Feb 2, 2016APRXNoNo► Subscribe► Subscribe
Covidien
LYMPHAZURIN
isosulfan blue
INJECTABLE;INJECTION018310-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Novartis
US Department of Justice
Mallinckrodt
Queensland Health
Cipla
Chubb
Cantor Fitzgerald
Daiichi Sankyo
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot